Haemorrhage remains the leading cause of death, despite the existence of effective clinical interventions, emphasising the ...

For decades, we have witnessed steady growth in the prevalence of overweight and obesity throughout the world. In some ...

GLP-1 receptor agonists were associated with better graft and patient survival. Clinical trials are needed to confirm these ...

Germany's likely new Chancellor inherits a series of plans for health reform and must deal with an ageing population and underinvestment in infrastructure. Ferry Biedermann reports.

More than 300 cases have been reported, which experts have linked to infection with Campylobacter jejuni. Samaan Lateef reports from Mumbai.

Founded 5 years ago, the Institute of HIV Research and Innovation works with communities to answer the research questions that matter most to them. Sima Barmania reports from Bangkok.

Libby Sallnow is Associate Professor in Palliative Care in the Marie Curie Palliative Care Research Department at University ...

Humanitarian assistance has saved millions of lives, improved public health outcomes, and strengthened communities in crisis.1 From responding to armed conflicts and natural disasters to advancing ...

In December, 2024, after more than 50 years in power in Syria, the regime of the Assad family was swept away. This dramatic ...

Tuberculosis remains one of the most lethal infectious diseases caused by a single pathogen. According to the latest global ...

On Dec 12, 2024, the US Food and Drug Administration (FDA) approved crinecerfont for adults and paediatric patients with ...

We thank Huixun Jia and Xiaodong Sun for their perspective on our study.1 The goals of this first-in-human trial were to identify safe doses of RGX-314 and an optimised protocol for advanced studies.